ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 859 filers reported holding ISHARES TR in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,928 | -3.7% | 580 | 0.0% | 0.06% | 0.0% |
| Q2 2023 | $73,637 | -1.7% | 580 | 0.0% | 0.06% | -6.2% |
| Q1 2023 | $74,913 | -1.6% | 580 | 0.0% | 0.06% | +1.6% |
| Q4 2022 | $76,148 | +12.0% | 580 | 0.0% | 0.06% | +6.7% |
| Q3 2022 | $68,000 | 0.0% | 580 | 0.0% | 0.06% | +15.4% |
| Q2 2022 | $68,000 | -16.0% | 580 | -6.9% | 0.05% | -1.9% |
| Q1 2022 | $81,000 | -14.7% | 623 | 0.0% | 0.05% | -7.0% |
| Q4 2021 | $95,000 | -5.9% | 623 | 0.0% | 0.06% | -1.7% |
| Q3 2021 | $101,000 | +6.3% | 623 | +7.4% | 0.06% | -50.4% |
| Q2 2021 | $95,000 | -43.8% | 580 | -53.4% | 0.12% | -69.1% |
| Q3 2020 | $169,000 | -1.2% | 1,245 | 0.0% | 0.38% | -6.7% |
| Q2 2020 | $171,000 | +27.6% | 1,245 | 0.0% | 0.41% | -21.3% |
| Q1 2020 | $134,000 | -53.6% | 1,245 | -48.0% | 0.52% | -11.3% |
| Q4 2019 | $289,000 | +6.6% | 2,395 | -3.4% | 0.58% | -66.5% |
| Q2 2019 | $271,000 | +95.0% | 2,480 | +100.0% | 1.74% | +121.3% |
| Q1 2019 | $139,000 | – | 1,240 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |